Reassortant Influenza Virus Generation With HA/NA Segment Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for generating reassortant influenza viruses, such as classical reassortment and reverse genetics, face challenges including the inability to control gene sequences, time-consuming isolation of desired viruses, and inefficiencies in producing high-yield viruses with compatible gene constellations, particularly for strains like H5 and H7.
Innovation Solution
A method involving contacting a culture host with a parent influenza virus strain and introducing an expression construct containing a second HA or NA gene, allowing for sequence manipulation and selection of diverse reassortant viruses with improved growth properties, while avoiding the limitations of classical reassortment and reverse genetics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If classical reassortment is used to generate reassortant influenza viruses, then the virus can be produced using traditional culture host inoculation, but the method cannot control gene sequences and produces mixed reassortant viruses with multiple gene constellation ratios
Solution Approach 1:
The influenza virus genome is divided into 8 separate segments (PB2, PB1, PA, HA, NP, NA, M, NS), allowing independent manipulation and selection of specific segments. This segmentation enables precise control over which segments are combined to create reassortant viruses with desired gene constellations, resolving the inability to control gene sequences in classical reassortment.
Solution Approach 2:
Different segments of the virus genome are treated with different qualities or characteristics. The invention selectively introduces specific segments (e.g., HA and NA from circulating strains) while maintaining others from high-growth strains, creating local variations in viral properties to achieve both growth efficiency and vaccine relevance.
2Productivity
If classical reassortment is used to produce reassortant viruses, then the culture host can be inoculated with both parent strains, but the isolation process becomes time-consuming due to the mixture of reassortant viruses
Solution Approach 1:
The invention performs preliminary actions by pre-selecting and pre-characterizing parent virus strains with specific growth properties and gene constellations before the reassortment process. This allows the desired reassortant viruses to be more readily identified and isolated, reducing the time required for virus isolation and characterization.
Solution Approach 2:
The invention employs feedback mechanisms through monitoring and analyzing virus growth characteristics, gene constellation ratios, and viral properties during the reassortment process. This feedback allows real-time adjustment of culture conditions and selection criteria to accelerate the isolation of desired reassortant viruses.
3Manufacturing precision
If reverse genetics is used to generate reassortant influenza viruses, then gene sequences can be manipulated, but the method requires complex in vitro assembly and transfection procedures
Solution Approach 1:
The invention uses an intermediary approach by employing a helper virus system that facilitates the introduction and expression of viral segments in host cells. This intermediary mechanism simplifies the complex transfection procedures required in reverse genetics by leveraging the natural replication machinery of the helper virus to deliver and process viral genetic material.
4Productivity
If H5 or H7 influenza strains are used as parent strains, then high growth characteristics can be achieved, but pathogenic determinants such as polybasic cleavage sites cannot be deleted using classical reassortment
Solution Approach 1:
The invention extracts and removes harmful pathogenic determinants (such as polybasic cleavage sites) from the viral genome segments. By selectively isolating and excluding these harmful elements during the reassortment process, the invention creates virus strains that maintain high growth characteristics while eliminating pathogenicity, enabling safe use in vaccine production.
Data Source
AI summary
A method for producing reassortant influenza viruses is provided. Also provided are reassortant influenza viruses produced according to the method, as well as vaccines based on said reassortant influenza viruses.